-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

802. Chemical Biology and Experimental Therapeutics: Poster III

Symposia: Chemical Biology and Experimental Therapeutics Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Manisha Du Plessis1*, Luis Daniel Mata Casimiro2*, Irmela Jeremias, MD3,4 and Olaf Heidenreich, PhD2,5,6

1Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
2Princes Máxima Center for Pediatric Oncology, Utrecht, Netherlands
3Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Munich, German Research Center for Environmental Health (HMGU), Munich, Germany
4German Cancer Consortium (DKTK), partner site Munich, a partnership between DKFZ and the Hospital of the Ludwig-Maximilians-University (LMU), Munich, Germany
5Wolfson Childhood Cancer Research Centre, Newcastle University, Newcastle upon Tyne, United Kingdom
6University Medical Center Utrecht, Utrecht, Netherlands

Justin Adeyeye1*, Cynthia R. Giver, PhD2, Jamie Cohen3*, Yuou Wang, PhD3*, Tysheena P. Charles, PhD4*, Khue G. Nguyen, PhD5*, Jian-Ming Li, PhD3*, Jens Wrammert, PhD4*, David A. Zaharoff, PhD5* and Edmund K. Waller, MD, PhD6

1Winship Cancer Institute Summer Scholars Research Program, Emory University, Atlanta, GA
2Emory University Winship Cancer Institute, Atlanta, GA
3Winship Cancer Institute, Emory University, Atlanta, GA
4Department of Pediatrics, Emory University, Atlanta, GA
5Department of Biomedical Engineering, North Carolina State University, Raleigh, NC
6Emory University, Winship Cancer Institute, Atlanta, GA

Jeffrey N Lindquist, PhD1*, Kai Qin, PhD2*, Jeffrey M Liu, PhD3*, Aaron M Ring, MD, PhD2* and Hirdesh Uppal, PhD1*

1Simcha Therapeutics, San Francisco, CA
2Fred Hutchinson Cancer Center, Seattle, WA
3Simcha Therapeutics, New Haven, CA

Darren C Phillips, PhD, BSc*, Luzivette Robles-Cardona*, Cory Alvey*, Justin Ingram*, Lloyd T Lam, PhD*, Ziping Yang*, Jacob J Riehm, MS*, Jun Chen, MD, PhD*, Matthew Kurnick*, Peter Kovar*, Jin Wang*, George Doherty*, Vikram Bhat*, Yujia Dai*, Andrew Judd* and Andrew Souers, PhD

AbbVie Inc., North Chicago, IL

Timo Ullrich1*, Birte Hernandez Alvarez2*, Christoph Pollmann3*, Malte Ulrich Ritter4*, Jérémy Haaf5*, Narges Aghaallaei, PhD6*, Jacob Piehler7*, Ivan Tesakov, MD8*, Maya El-Riz9*, Kateryna Maksymenko1*, Valeriia Hatskovska5*, Sergey Kandabarau10*, Maksim Klimiankou, PhD11*, Claudia Lengerke, MD12, Karl Welte, MD, PhD13, Andrei Lupas, PhD1*, Julia Skokowa, MD, PhD11 and Mohammad ElGamacy, PhD14*

1Department Protein Evolution, Max Planck Institute for Biology, Tuebingen, DEU
2Department Protein Evolution, Max Planck Institute for Biology, Tuebingen, Germany
3Department of Biology/Chemistry and Center for Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany
4Department of Oncology, Hematology, Clinical Immunology, and Rheumatology, University Hospital Tuebingen, Tuebingen, BW, Germany
5Department of Oncology, Hematology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, DEU
6University Hospital Tübingen, Tübingen, DEU
7Department of Biology/Chemistry and Center for Cellular Nanoanalytics, University of Osnabruck, Osnabruck, DEU
8Department of Oncology, Hematology, Immunology, Rheumatology and Clinical Immunology, University Hospital Tübingen, Tübingen, DEU
9Department of Biology/Chemistry and Center for Cellular Nanoanalytics, Osnabrück University, OsnabrüCk, DEU
10Department of Oncology, Hematology, Clinical Immunology, and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany
11Department of Oncology, Hematology, Immunology, Rheumatology and Clinical Immunology, University Hospital Tübingen, Tübingen, Germany
12Department for Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany
13Pediatric Hematology and Oncology, The University Children's Hospital Tuebingen, Tuebingen, Germany
14Department of Oncology, Hematology, Clinical Immunology, and Rheumatology, University Hospital Tuebingen, Tuebingen, DEU

Maura Lima Pereira Bueno1*, Charles Ayemoba2*, Anna M Di Staulo2*, Sen Zhang, PhD2*, Fernanda Soares Niemann, MSc1*, Nádia Ghinelli Amôr, PhD1*, Irene Santos, MSc1*, Adriana da Silva Santos Duarte, PhD1*, Audrey Bastos1*, Sara Teresinha Olalla Saad, MD PhD1, Sandra Pinho, PhD2 and Fernanda Marconi Roversi, PhD1,3*

1Hematology and Transfusion Medicine Center, State University of Campinas – UNICAMP, Campinas, Brazil
2Department of Pharmacology & Regenerative Medicine, University of Illinois at Chicago, Chicago, IL
3Department of Surgery, Emory University, Atlanta

Neeraj K Aryal, PhD1*, Thomas Frost, PhD1*, Yuhan Huang1*, Bo Kyung Alex Seong, PhD1*, Lisa Drew, PhD1* and Omid Tavana2*

1AstraZeneca, Waltham, MA
2AstraZeneca Early Oncology R&D TDE, Waltham, MA

Yupeng Zheng, Ph.D.1*, Walter F Lenoir, Ph.D.1*, Marek J Kobylarz, Ph.D.2*, Jun Li1*, Tamara D Hopkins, PhD2*, Michael R McKeown, PhD2*, Michelle G. Shum2*, Kameron R Mori2*, Elizabeth C Townsend, Ph.D.1*, Benjamin W Trotter, Ph.D.2*, Peter B Rahl, Ph.D.2*, Nikolaus D Obholzer, PhD2* and Charles Y Lin, PhD2

1Kronos Bio, cambridge, MA
2Kronos Bio, Inc., Cambridge, MA

Sarada Ketharnathan, PhD1, Serkan Dogan1*, Sujata Pokharel1*, Sergey V Prykhozhij, PhD1*, Anna Cordeiro, PhD2*, Irina Alecu3*, William Mannherz, PhD4, Mira Liebman, MD5*, Elaine W. Leung, MD, FRCPC5, Steffany Bennett3*, Miroslava Cuperlovic-Culf6*, Suneet Agarwal, MD, PhD4, Yigal Dror, MD, FRCPC7 and Jason N. Berman, MD1

1CHEO Research Institute, Ottawa, ON, Canada
2AGADA Biosciences, Halifax, NS, Canada
3Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, CAN
4Boston Children's Hospital, Boston, MA
5Children's Hospital of Eastern Ontario, Ottawa, ON, CAN
6Digital Technologies Research Centre, National Research Council of Canada, Ottawa, ON, CAN
7Marrow Failure and Myelodysplasia Program, Division of Haematology and Oncology, The Hospital for Sick Children, Toronto, ON, Canada

*signifies non-member of ASH